Intestinal Permeability in Cystic Fibrosis in Relation to Genotype

Author:

Hallberg K.1,Grzegorczyk A.2,Larson G.2,Strandvik B.1

Affiliation:

1. Department of Pediatrics Göteborg University Göteborg Sweden

2. Clinical Chemistry and Transfusion Medicine Göteborg University Göteborg Sweden

Abstract

Background:The purpose of this study was to investigate whether the increased intestinal permeability (IP) seen in patients with cystic fibrosis (CF) is correlated with the basic defect, as revealed by the patient's genotype, and/or whether the intestinal disturbance reflects secondary abnormalities such as essential fatty acid deficiency.Methods:Nineteen CF patients were compared with nine age‐ and sex‐ matched healthy controls. IP was evaluated by studying urinary excretion for 5 hours after a test meal containing lactulose, L‐rhamnose and xylose in water. Urine was analyzed for carbohydrates, and blood samples were taken for determination of the fatty acid pattern of serum phospholipids. The CF patients were grouped according to genotype: homozygous for ΔF508, heterozygous for ΔF508, or unidentified.Results:Patients who were homozygous (n = 9) or heterzygous (n = 6) for ΔF508 had significantly higher lactulose/L‐rhamnose excretion ratios (mean(range) values of 0.08(0.05‐0.13) and 0.09(0.03‐0.13), respectively) than patients (n = 4) with unidentified genotypes [0.03(0.02‐0.05); p = 0.005] or healthy controls [0.02(0.003‐0.06); p = 0.002]. CF patients with EFAD (n = 6) did not differ from those with a normal pattern of serum phospholipid fatty acids, the lactulose/L‐rhamnose excretion ratio being 0.08(0.02‐0.13) and 0.07(0.03‐0.12), respectively.Conclusions:These data show that the IP in CF was related to patient genotype; those homozygozous or heterozygous for ΔF508 having a significantly increased IP compared with patients with unidentified genotypes, who had IP values within the normal range.

Funder

Medicinska Forskningsrådet

Publisher

Wiley

Reference39 articles.

1. Ion transport abnormalities in the intestine in cystic fibrosis;Hardcastle J;Pediatr Pulmonol Suppl,1990

2. Enhanced glucose absorption in the jejunum of patients with cystic fibrosis;Frase LL;Gastroenterology,1985

3. Small bowel mucosal dysfunction in patients with cystic fibrosis;Morin CL;J Pediatr,1976

4. Lactulose‐rhamnose intestinal permeability in children with cystic fibrosis;Leclercq‐Foucart J;J Pediatr Gastroenterol Nutr,1987

5. Intestinal malabsorption in cystic fibrosis;Penny DJ;Arch Dis Child,1986

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3